Shares of Mankind Pharma Ltd were trading in the red today even as the pharma firm said its board has approved the closure of ...

In a meeting held on December 20, 2024, the Fund Raising Committee of the company had approved the issue of 1.19 crore equity ...

The equity shares will be allotted to the eligible QIBs at an issue price of ₹2,520 per share - a price which includes a ...

Mankind Pharma said that its board has approved the closure of the issue for the qualified institutions placement of equity shares of the company on Thursday, 19 December 2024.

Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from Rs 40,06,62,138 consisting 40,06,62,138 equity shares to Rs 41,25,66,899 consisting 412566899 equity ...

AM(IST)on Friday in a weak market. Dr. Reddy's Laboratories Ltd.(up 2.37 per cent), Aurobindo Pharma Ltd.(up 1.32 per cent), Divi's Laboratories Ltd.(up 1.28 per cent), Granules India Ltd.(up 0.71 per ...

Benchmark NSE Nifty50 index ended down 364.21 points at 23587.5, while the BSE Sensex stood 1176.46 points at 78041.59. Among ...

Mankind Pharma has exhibited a significant bullish breakout from an Adam & Eve pattern on the daily chart, indicating robust accumulation at higher levels. This breakout underscores the continuation ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,12,418.74 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

Mankind Pharma Limited has informed the exchange regarding allotment of 11904761 securities pursuant to qualified institution placement at its meeting held on December 20, 2024 ...

This Rs 572 crore IPO consists of a fresh issue of up to 2.05 crore equity shares, with the proceeds earmarked for expanding ...

House Votes Down Bill to Keep Government Open Past Friday Speaker Mike Johnson rushed the bill to a vote after President-elect Trump told Republicans to kill a bipartisan measure that had been ...